- Global Pharma News & Resources

Digital PCR Market exhibiting CAGR of 19% from 2023 to 2032, owing to the increasing use of biomarker profiling for disease diagnostics | insightSLICE

The global Digital PCR market size was estimated to be US$ 430 million in 2021 and is expected grow at a CAGR of 19% between 2023 to 2032.

The Digital PCR Market study will give details on market trends, analyses, and forecasts for the years 2022–2032. Where 2020 represents the historical period, 2021 is the baseline period, and the projected period runs from 2022 through 2032.

Access the sample report:

The study also takes into account the competitive environment, and the report will give an overview of the major competitors in the global market for Digital PCR products as well as their market forecasts.

In addition, the report will include information on important advancements, global and regional sales networks, business strategies, research and development initiatives, workforce, and top-level managers for all significant business competitors.

The key players of the Global Digital PCR Market are:

Thermo Fisher Scientific, Qiagen N.V. (Formulatrix, Inc.), Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Sysmex Corporation (Sysmex Inostics GmbH), JN Medsys, Merck KGaA, Expedeon AG, Fluidigm Corporation, Stilla Technologies, and Sysmex Corporation.

Increasing use of digital PCR systems across the globe:

The incidence of genetic abnormalities and infectious diseases increased acceptance of biomarker profiling-based diagnostic procedures, rising investment in gene therapy and government initiatives to create novel medications are the main factors propelling the worldwide digital PCR market.

A quantitative measurement technique for determining the amount of DNA or RNA in a sample without relying on a calibration curve is digital PCR. Because of its excellent accuracy, better rare gene & CNV detection, and high detection sensitivity, digital PCR is widely used throughout clinical applications.

The research and development of molecular biomarkers for the advancement of precision or personalized medicine heavily rely on digital PCR.

The global digital PCR market is being actively driven by rising demand for biomarker-based prediction and diagnosis of chronic conditions like cancer, as well as the adoption of customized medicine for enhanced treatment. As a result, the worldwide digital PCR market is anticipated to expand significantly over the next years.

Read more about the report inclusions:

Extensive and intricate coverage of the digital PCR industry:

With an emphasis on important players participating in the global digital PCR market, this study offers an in-depth analysis of leading companies with a majority share of the global market.

The company division that deals with digital PCR devices can then be found using this information. We’ll additionally calculate the market dominance of well-known firms in the worldwide digital PCR industry.

All of the digital PCR firms’ business strategies, product portfolios, important developments, SWOT analyses, and development and research priorities are taken into account in the research.

The players along with supply chain members and market dynamics of the market, as well as their contributions, will be taken into account in the worldwide digital PCR research report. The company’s whole line of products falling under its digital PCR business sector will be the focus of the brand portfolio.

Similar to this, the recent developments section would concentrate on the most recent firm developments, including geographic expansion, mergers and acquisitions, the launch of new products, and strategic alliances and collaborations in the global digital PCR industry.

Related reports:

Global Incontinence Care Products Market:

Global Prefilled Syringes Market:

Global Digital PCR Market Key Segments:

By Product

  • Instruments
  • Reagents & Consumables

By Indication

  • Infectious Diseases
  • Oncology
  • Genetic Disorders
  • Others

By End Use

  • Hospitals & Clinics
  • Pharmaceutical companies
  • Diagnostic centers
  • Academic & Research Organizations

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Regional performance of Digital PCR Market

Due to its early adoption of cutting-edge diagnostic technologies, extensive genetic research & development network, and rising investment in the creation of novel genomic technologies, North America accounted for the highest share of the global market in 2019.

The desire for the development of personalized medicine is also being fueled by the rising incidence of cancer, which is propelling the expansion of the North American digital PCR market. Given the prevalence of chronic diseases and its growing population, the United States performs a significant portion of the world’s surgical procedures.

The main drivers of the popularity of digital PCRs in North America include the rise in cancer cases, the frequency of contagious diseases, and the development of mobile digital PCRs.

A growing population and more investment in bolstering the healthcare infrastructure are expected to make Asia Pacific a lucrative market for digital PCR producers in the years to come.

The prevalence of long-term diseases and the rise in health tourism are projected to be the main drivers of the Asia Pacific digital PCR market throughout the forecast period.

A significant portion of the worldwide digital PCR market is expected to come from Europe during the projected period as a result of rising investments in the production of new diagnostic tools and medicines.

In the upcoming years, it is projected that Asia Pacific will have significant growth, supported by rising investment in bolstering the biotechnology and pharmaceutical industries.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 02-Dec-2022